520 Results

People

  1. Postow
    Postow
  2. Motzer
    Motzer
  3. Wolchok
    Wolchok
  4. Hellmann
    Hellmann
  5. Shoushtari
    Shoushtari
  6. Voss
    Voss
  7. Callahan
    Callahan
  8. Abou-Alfa
    Abou-Alfa
  9. Jones
    Jones
  10. Rosenberg
    Rosenberg

Groups

  1. Department of Medicine (394)
  2. Solid Tumor Oncology Division (337)
  3. Hematologic Malignancies, Division of (108)
  4. Melanoma and Immunotherapeutics Service (108)
  5. Genitourinary Oncology Service (101)
  6. Melanoma Disease Management Team (96)
  7. GSK Faculty (83)
  8. Surgery (71)
  9. Gastrointestinal Oncology Service (65)
  10. Weinberg Fellows (61)
  1. "nivolumab"
Formats
  1. Journal Article (342)
  2. Review (93)
  3. Editorial (41)
  4. Meeting Abstract (18)
  5. Correspondence (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Book Section (4)
  9. Conference Paper (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (394)
  2. Solid Tumor Oncology Division (337)
  3. Hematologic Malignancies, Division of (108)
  4. Melanoma and Immunotherapeutics Service (108)
  5. Genitourinary Oncology Service (101)
  6. Melanoma Disease Management Team (96)

More Groups

People
  1. Michael Postow (55)
  2. Robert Motzer (50)
  3. Jedd Wolchok (41)
  4. Margaret Callahan (28)
  5. Alexander Shoushtari (27)
  6. Matthew Hellmann (26)

More People

Years
  1. 2025 (35)
  2. 2024 (70)
  3. 2023 (75)
  4. 2022 (52)
  5. 2021 (45)
  6. 2020 (64)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (23)
  2. Journal of Clinical Oncology (22)
  3. Journal of Thoracic Oncology (21)
  4. Lancet Oncology (21)
  5. New England Journal of Medicine (19)
  6. Annals of Oncology (17)

More Publications

Publishers
  1. Elsevier Inc. (77)
  2. Elsevier Science, Inc. (50)
  3. Oxford University Press (35)
  4. Wiley Blackwell (32)
  5. Biomed Central Ltd (27)
  6. Nature Publishing Group (27)

More Publishers

Results (520)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases
    Journal Article

    Singh, C.; Qian, J. M.; Yu, J. B.; Chiang, V. L.
    Journal of Neurosurgery (2020)

    Fulltext@MSK | Save
  • Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%
    Journal Article

    Gainor, J. F.; Rizvi, H.; Jimenez Aguilar, E.; Skoulidis, F.; Yeap, B. Y.; Naidoo, J.; Khosrowjerdi, S.; Mooradian, M.; Lydon, C.; Illei, P.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Intravitreous cutaneous metastatic melanoma in the era of checkpoint inhibition: Unmasking and masquerading
    Journal Article

    Francis, J. H.; Berry, D.; Abramson, D. H.; Barker, C. A.; Bergstrom, C.; Demirci, H.; Engelbert, M.; Grossniklaus, H.; Hubbard, B.; Iacob, C. E.; more...
    Ophthalmology (2020)

    Fulltext@MSK | Save
  • Overview of established and emerging immunohistochemical biomarkers and their role in correlative studies in MRI
    Review

    Alvi, E.; Gupta, R.; Borok, R. Z.; Escobar-Hoyos, L.; Shroyer, K. R.
    Journal of Magnetic Resonance Imaging (2020)

    Fulltext@MSK | Save
  • Progress toward precision medicine in frontline treatment of metastatic renal cell carcinoma
    Editorial

    Singla, N.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Checkpoint inhibitors in AML: Are we there yet?
    Review

    Ghosh, A.; Barba, P.; Perales, M. A.
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • B cells and tertiary lymphoid structures promote immunotherapy response
    Journal Article

    Helmink, B. A.; Reddy, S. M.; Gao, J.; Zhang, S.; Basar, R.; Thakur, R.; Yizhak, K.; Sade-Feldman, M.; Blando, J.; Han, G.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Immune therapy for liver cancers
    Review

    Hilmi, M.; Vienot, A.; Rousseau, B.; Neuzillet, C.
    Cancers (2020)

    Fulltext@MSK | Save
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save
  • EURACAN/IASLC Proposals for updating the histologic classification of pleural mesothelioma: Towards a more multidisciplinary approach
    Guidelines

    Nicholson, A. G.; Sauter, J. L.; Nowak, A. K.; Kindler, H. L.; Gill, R. R.; Remy-Jardin, M.; Armato, S. G. 3rd; Fernandez-Cuesta, L.; Bueno, R.; Alcala, N.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save